ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

721
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bullish•Abbott Laboratories
•30 Nov 2020 19:43

Biden COVID-19 Response Plan: Overview of Its Inherent Investment Themes

Biden's recently-announced COVID-19 response plan suggests a number of investment themes. This Insight overviews the more significant of those...

Logo
366 Views
Share
bearish•Cross Asset Strategy
•30 Sep 2020 08:23

Korea Stock Market Monthly Recap #52 (September 2020)

Review of Top 10 Issues Related to Korean Stock Market, Economy, Politics in September 2020

Logo
413 Views
Share
•09 Sep 2020 12:18

The Stocks to Own in Asia – Vol. 30

We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asia markets...

Share
•30 Aug 2020 01:22
Smartkarma Originals

Asian Governance: Diversity & Incentives Through the Cultural Lens

In this Smartkarma Original, we seek to study how diversity and incentives influence stock performance and profitability. We tallied diversity and...

Logo
969 Views
Share
bearish•MSCI ACWI Index
•03 Apr 2020 10:05

Global Equities (ACWI-US) Likely to Retest the March Low

We continue to believe global equities (ACWI-US) are likely to test the recent low made on March 23, with an undercut of roughly 10% also in the...

Logo
599 Views
Share
x